FIRST EXPERIENCE OF PERSONALIZED IN SITU TISSUE ENGINEERING FOR THORACIC SURGERY OF THE SARCOMA PATIENT: MSCS-CONTAINING MINIMALLY MANIPULATED CELLS AND AN INDIVIDUALIZED MICROPORE TITANIUM STERNUM IN A ONE-YEAR FOLLOW-UP CASE REPORT ArticleKolobaev I.V., Usachev V.S., Klabukov I.D., Afonin G.V., Aleksandrov O.A., Usacheva A.Y., S. Shklyaev Stanislav, Grivtsova L.Y., Kabanov D.O., Rubtsova N.A., Shegay P.V., Ivanov S.A., Kaprin A.D., Baranovskii D.S.International Journal of Hematology-Oncology and Stem Cell Research. 2025.
